ALLENDALE, Mich.–(BUSINESS WIRE)–Dr. Phil Doren, Chief Executive Officer, announced today that Dr. Susan Walker is a member of the Board of Directors of Abond CRO Inc.

Dr. Walker is an independent consultant and the immediate past director of the Division of Dermatology and Dental Products (DDDP) at the US Food and Drug Administration (FDA). From 2006 to 2014 she led this division of over 40 senior physicians, scientists, and staff with responsibilities for review and approval of regulatory applications, including New Drug Applications, Biologics Licensing Applications, Investigational New Drug Applications, labeling supplements, Pediatric Study Plans, Risk Evaluation and Mitigation Strategies, and other submissions. As division director, responsibilities included leading meetings with industry regarding drug and biologic development programs; management of advisory committee activities; development and implementation of clinical guidance documents, and managing diverse cross-discipline and cross-center teams. During her tenure as Division Director she led the regulatory approval of dermatology products in the transition from a primarily topical focus to the current broader focus, with the introduction of systemic biologic agents. She has received multiple FDA awards for professional, scientific and administrative contributions.

Dr. Walker is a fellow of the American Academy of Dermatology, a member of the American Dermatological Association, and is board certified in Dermatology (1990). She has an active medical license in Maryland. Previous to FDA, she served as the Chief, Dermatology Section at the Veterans Administration in Martinez, CA with a faculty appointment at the University of California, Davis and responsibility for various clinical research projects and residency training.

Dr. Walker’s experience includes 18 years at FDA serving in multiple leadership positions across FDA Centers, including medical reviewer, Lead Medical Officer, and Division Director (Dermatology) in the Center for Drug Evaluation and Research (CDER); (acting) deputy director in the Division of General, Reconstructive, and Neurological Devices the Center for Devices and Radiologic Health (CDRH); Associate Director for Clinical Affairs in the Office of Nutritional Products, Labeling, and Dietary Supplements; and Director of the Division of Dietary Supplement Programs in the Center for Food Safety and Nutrition (CFSAN). She has given presentations and led sessions at multiple dermatology meetings and participated in professional publications.

About Abond CRO Inc. (

Abond is a full-service clinical research organization dedicated to providing specialized clinical research support for the pharmaceutical and medical device industries since its founding in 1974 (incorporation in 1985). They deliver everything you’d expect from a full-service CRO — consulting, clinical operations, data management, statistical analysis — and a few things that set them apart: honesty, focus, and responsibility. Abond works with small startup organizations to established pharmaceutical and medical device leaders around the world.


Abond CRO Inc.
Charley Bratton